PRIMARY MEDIASTINAL B-CELL LYMPHOMA
Clinical trials for PRIMARY MEDIASTINAL B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MEDIASTINAL B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY MEDIASTINAL B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lymphoma patients may avoid unnecessary radiation with new study
Disease control OngoingThis study looks at people with a type of lymphoma (PMLBCL) who finished standard chemo-immunotherapy and had a PET/CT scan showing no active tumor. Half will get radiation therapy as usual, and half will just be watched closely. The goal is to see if careful observation works ju…
Matched conditions: PRIMARY MEDIASTINAL B-CELL LYMPHOMA
Phase: NA • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
CAR t cell therapy: 15-Year safety check begins for lymphoma patients
Knowledge-focused OngoingThis study follows about 50 people who have already received an experimental CAR T cell therapy for certain types of lymphoma. The goal is to track any long-term side effects and survival for up to 15 years after treatment. No new study drug is given, but participants may receive…
Matched conditions: PRIMARY MEDIASTINAL B-CELL LYMPHOMA
Sponsor: Adicet Therapeutics • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC